Cytovance Biologics, a leading full-service contract manufacturer of mammalian and microbial biologics, announced today its receipt of the 2012 CMO Leadership Award as a category leader for Reliability.

The CMO Leadership Award is based on industry research conducted by Nice Insight and presented by Life Science Leader Magazine. Cytovance scored a 75% customer perception (CP) rating by Nice in Q4 -- an increase from Q3.

According to Life Science Leader, the awards were developed to better serve pharmaceutical and biopharmaceutical executives in their vetting process of CMOs. The awards represent the opinions of over 3,000 pharmaceutical and biopharmaceutical executives and only CMOs who were in the top 20% of each perception category qualified for a CMO Leadership Award.

"We are honored to be recognized by our clients as a Liquid Dose Manufacturing leader for Reliability," stated Darren Head, President and Chief Executive Officer of the company. "Cytovance Biologics takes pride in being a reliable, value-added partner with our clients in providing integral pathways of converting today's novel protein discoveries into future life saving therapies. This award is possible thanks to our highly experienced employees that consistently demonstrate commitment to service. We accept this award as a testament to the dedication and hard work of many within our remarkable company."

Cytovance was recognized as a category leader in 2011 for Regulatory and Productivity.

About Cytovance® Biologics

Cytovance® Biologics is a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. In addition to its cGMP manufacturing services, the company offers process development, cGMP cell banking and support services from its Oklahoma City state-of-the-art facilities.